Navigation Links
ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease
Date:12/7/2009

MOUNTAIN VIEW, Calif., Dec. 7 /PRNewswire/ -- In addition to data released in late November, ChemoCentryx, Inc., announced today more data from the Company's PROTECT-1 (the Prospective Randomized Oral Therapy Evaluation in Crohn's disease Trial) of Traficet-EN(TM) (CCX282-B) in patients with moderate-to-severe Crohn's disease. While the earlier announcement concerned the Induction period of the study, new data from the Maintenance period of the study showed that a statistically significant number of patients receiving continuous therapy of Traficet-EN versus placebo for 36 weeks were in clinical remission of Crohn's disease, defined as a score of 150 points or less in the Crohn's Disease Activity Index (CDAI). At week 36, a statistically significant percentage of patients receiving Traficet-EN versus placebo were in corticosteroid-free remission. Traficet-EN continued to be safe and well-tolerated after extended use. Additionally, conclusive evidence was provided that the involvement of the CCR9 and its chemokine ligand (TECK) in inflammatory bowel disease (IBD) is not just restricted to the small bowel, but is relevant to inflammation of the large bowel as well.

The new Crohn's disease clinical remission findings, as well as the expanded understanding of the role of CCR9 and its ligand TECK in the gastrointestinal system (GI) tract, were highlighted in poster and oral presentations titled "PROTECT-1 Maintenance Phase Study Results Demonstrate Efficacy of the Intestine-Specific Chemokine Receptor Antagonist CCX282-B (Traficet-EN) in Crohn's Disease" and "CCR9 Inhibition in the Treatment of Colonic Inflammation" at the 2009 Advances in Inflammatory Bowel Diseases, Crohn's & Colitis Foundation's Clinical & Research Conference in Hollywood, Florida.

Traficet-EN is an orally-active antagonist of the chemokine receptor known as 'CCR9', which is selectively expressed by inflammatory T cells that migrate to the digestive t
'/>"/>

SOURCE ChemoCentryx, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference
2. PROTECT-1 Phase II/III Induction-Stage Results for ChemoCentryxs Traficet-EN(TM) Presented in Oral Session at DDW 2009 Conference
3. ChemoCentryx Completes Enrollment of PROTECT-1, a Phase II/III Clinical Trial of CCR9 Antagonist CCX282-B (Traficet-EN(TM)) in Crohns Disease
4. ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354
5. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology
6. TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology (ASH) Annual Meeting
7. Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution
8. Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis
9. NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico
10. ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514
11. Pharmasset Reports Fiscal Year End 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... BRIDGEWATER, N.J. , May 5, 2015  CorMedix ... developing and commercializing therapeutic products for the treatment of ... 2015 financial results on May 7.  Randy Milby ... investor conference call on Friday, May 8 at 9:00 ... in the conference call, please call 1-877-407-8031 (U.S.), 1-201-689-8031 ...
(Date:5/5/2015)... 5, 2015   InspireMD, Inc. (NYSE MKT: NSPR) ... announced today that it will release its full financial results ... May 11 th before the open, followed by a ... results and business outlook. Participants should call (888) ... (International) and request the InspireMD call. A live webcast of ...
(Date:5/5/2015)... LONDON , May 5, 2015 ... or the "Company"), a biopharmaceutical company focused on ... proprietary cannabinoid product platform, announced today the closing ... Global Market by GW of 1,600,000 American Depositary ... ADS, raising gross proceeds of approximately $179.2 million ...
Breaking Medicine Technology:CorMedix, Inc. to Report First Quarter Financial Results on May 8, 2015 2InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 2InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 3GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 2GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 3GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 4
(Date:5/5/2015)... 05, 2015 The global lab automation ... from $3,474.2 Million in 2014, at an estimated CAGR ... the lab automation market on the basis of equipment ... region. On the basis of application, Lab Automation Market ... and proteomics solutions. Drug discovery is a major application ...
(Date:5/5/2015)... From the halls of Microsoft Ignite ... enabling enterprise collaboration across platforms and devices, today ... and simplify the move to Microsoft Office 365. ... Office 365 enable organizations to migrate to ... adoption and effectively managing critical business data on ...
(Date:5/5/2015)... Baptist Medical Center Jacksonville’s cancer program has ... the American College of Surgeons. , To earn the ... 30 Commission on Cancer quality care standards, be evaluated ... levels of excellence in the delivery of comprehensive patient-centered ... care locally at a CoC-accredited cancer center, they are ...
(Date:5/5/2015)... 05, 2015 Nutritional science and medical ... a variety of health conditions and illnesses linked to ... to adopt clean eating methods to rid the body ... with over-consumption of fast and processed foods. Patients find ... to follow and report feeling better and losing excess ...
(Date:5/5/2015)... May 05, 2015 In a April 25, ... The Herald-Times , the Missouri State Highway Patrol (MSHP) announced ... production or use for the second year in a row. ... the FBI, reported 1,469 incidents in 2014 alone, around 15% ... around 2% of the US Population calls Indiana home, according ...
Breaking Medicine News(10 mins):Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 2Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 3Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 4Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 5Health News:AvePoint Unveils New Solutions for Microsoft Office 365 & Azure at Microsoft Ignite 2015 2Health News:AvePoint Unveils New Solutions for Microsoft Office 365 & Azure at Microsoft Ignite 2015 3Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 2Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 3Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 4Health News:Diet Doc Introduces Diet Plans that Teach Patients how to Eat Clean by Getting Back to Basics and Exchanging Processed Foods for Clean, Nutritious Foods 2Health News:Diet Doc Introduces Diet Plans that Teach Patients how to Eat Clean by Getting Back to Basics and Exchanging Processed Foods for Clean, Nutritious Foods 3Health News:A Forever Recovery Releases New Information on the Epidemic Rise Of Methamphetamine Abuse in Midwest America 2
... be sure none rubs off on children, agency says , , ... troubling health effects if they come into contact with topical ... Food and Drug Administration on Thursday announced that two of ... risk. , Accidental pediatric exposures to the gels can occur ...
... Incorporated (NYSE: DGX ), the world,s leading ... it is scheduled to speak at the Bank of ... York City on Tuesday, May 12, 2009. The ... p.m. Eastern Time.During the conference, the company will reaffirm ...
... to seek immunity , , THURSDAY, May 7 (HealthDay News) -- ... in the United States was approaching 1,900, federal health officials ... transmission and not some link to Mexico, as was the ... , "Only about 10 percent of confirmed cases have a ...
... Maine, May 7 New research shows that Wild ... and decreasing the vulnerability of blood vessels to oxidative ... Feb; 12(1): 21-8 and Journal of Nutritional Biochemistry ... growing body of research supporting the potential protective effect ...
... young artists from across the country to submit creative works ... orphaned by HIV/AIDS around the world each day. The grand-prize ... art during the WWO 2009 Gala in New York City ... the annual gala. The three runners-up will receive $50 gift ...
... a Senator Last Year, Obama Voted for $9.6 Billion Annually ... President Proposes Only $6.6 Billion in FY,10 Budget for PEPFAR ... Congress Voted for $48B Over Five YearsWASHINGTON, May 7 ... the largest non-profit HIV/AIDS organization in the US, which currently ...
Cached Medicine News:Health News:FDA Orders Label Warning for Testosterone Gels 2Health News:FDA Orders Label Warning for Testosterone Gels 3Health News:Quest Diagnostics to Speak at the Bank of America and Merrill Lynch 2009 Healthcare Conference 2Health News:U.S. Swine Flu Count Nears 1,900; Person-to-Person Transmission Now Common 2Health News:U.S. Swine Flu Count Nears 1,900; Person-to-Person Transmission Now Common 3Health News:U.S. Swine Flu Count Nears 1,900; Person-to-Person Transmission Now Common 4Health News:U.S. Swine Flu Count Nears 1,900; Person-to-Person Transmission Now Common 5Health News:U.S. Swine Flu Count Nears 1,900; Person-to-Person Transmission Now Common 6Health News:U.S. Swine Flu Count Nears 1,900; Person-to-Person Transmission Now Common 7Health News:U.S. Swine Flu Count Nears 1,900; Person-to-Person Transmission Now Common 8Health News:U.S. Swine Flu Count Nears 1,900; Person-to-Person Transmission Now Common 9Health News:U.S. Swine Flu Count Nears 1,900; Person-to-Person Transmission Now Common 10Health News:New Research Demonstrates that Wild Blueberries May Support Cardiovascular Health 2Health News:New Research Demonstrates that Wild Blueberries May Support Cardiovascular Health 3Health News:YOUNG ARTISTS Competition: Beginning May 7th, World AIDS Orphans Day 2Health News:Budget: Obama Retreats on Global AIDS, Says AHF 2
... I system consists of four basic components: sample ... metal clamping plate (see diagram). The sample well ... spots, dots, or slots (see below). All three ... an accessory plate in conjunction with a complete ...
... Bio-Dot SF (slot format) microfiltration units provide ... nucleic acid in solution onto nitrocellulose or ... accommodated by using interchangeable templates to form ... format Bio-Dot SF apparatus. Each is available ...
... and Bio-Dot SF (slot format) microfiltration units ... or nucleic acid in solution onto nitrocellulose ... be accommodated by using interchangeable templates to ... slot format Bio-Dot SF apparatus. Each is ...
... clear, APET plastic tray. Ideal for staining ... trays used for multipurposes. Pour spouts in ... marker or label may be used for ... on rockers or shakers for staining several ...
Medicine Products: